Lower Limb Flexibility in Duchenne Muscular Dystrophy: Effects on Functional Performance

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03534349

Enrollment

Registered

2018-05-23

Start date

2017-01-31

Completion date

2017-12-31

Last updated

2018-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Duchenne Muscular Dystrophy, Flexibility, Performance

Keywords

Duchenne Muscular Dystrophy, lower limb flexibility, performance

Brief summary

The investigator investigated the effect of lower limb flexibility on functional performance of children with Duchenne Muscular Dystrophy.

Detailed description

Thirty children whose functional levels were in 1 or 2 according to the Brooke Lower Extremity Functional Classification Scale were included in the study. Flexibilities of hamstrings, hip flexors, tensor fascia latae, and gastrocnemius muscles were evaluated in dominant lower limb. Popliteal angle test, hip flexor flexibility test, tensor fascia latae flexibility test and gastrocnemius flexibility test were used for flexibility asssessments. Functional performance was assessed with 6 Minute Walk Test (6 MWT) and Timed Performance Tests. The correlation between the flexibility of lower limb muscles' and performance tests were examined.

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

OTHER

Eligibility

Sex/Gender

MALE

Age

5 Years to No maximum

Healthy volunteers

Inclusion criteria

* Having a Duchenne Muscular Dystrophy diagnosis, * Being in the ambulatory period and climbing four steps independently, * To be able to cooperate the physiotherapist's directions, * Not having any severe contracture in the lower limbs which may prevent assessments, * Not having any injury or surgery involving the lower limbs during the last 6 months.

Exclusion criteria

Children who did not provide these criteria and did not will to participate the study were excluded.

Design outcomes

Primary

Measure	Time frame	Description
6 Minute Walk Test	6 Minute	The 6 Minute Walk Test (6MWT) is a standard test recently used to evaluate functional capacity in neuromuscular diseases, and found to be a safe and valid test that can be performed in Duchenne Muscular Dystrophy

Secondary

Measure	Time frame	Description
Timed Performance Test	3 minute	Timed performance tests such as 10 m walk, Gower's (from supine position to stand up), ascending/descending 4 steps were also performed. During these tests, the child's performance was recorded in seconds.

Countries

Turkey (Türkiye)

Outcome results